A PDZ domain protein interacts with the C-terminal tail of the insulin-like growth factor-1 receptor but not with the insulin receptor

被引:43
作者
Ligensa, T
Krauss, S
Demuth, D
Schumacher, R
Camonis, J
Jaques, G
Weidner, KM
机构
[1] Roche Diagnost GMBH, Pharma Res, Dept Mol Biol, D-82372 Penzberg, Germany
[2] Inst Curie, INSERM, U248, F-75248 Paris, France
[3] Univ Marburg, Zentrum Innere Med, Hamatol Onkol Abt, D-35033 Marburg, Germany
关键词
D O I
10.1074/jbc.M104509200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we report on the isolation of a PDZ domain protein, here designated as IIP-1, insulin-like growth factor-1 (IGF-1) receptor-interacting protein-1, which binds to the IGF-1 receptor, but not to the related insulin receptor, and which is involved in the regulation of cell motility. The interaction between the IGF-1 receptor and IIP-1 as well as a splice variant IIP-1/p26 was demonstrated in the yeast two-hybrid system. Using co-precipitation experiments, we confirmed the interaction in transfected cells as well as in vitro. Analysis of deletion mutants indicates that the PDZ domain of IIP-1 mediates interaction with the C-terminal tail of the IGF-1 receptor (serine-threonine-cysteine). This finding demonstrates that the C terminus of the IGF-1 receptor acts as novel PDZ domain binding site. Immunofluorescence analysis revealed an overlapping localization of IIP-1 and the IGF-1 receptor in the breast cancer cell line MCF-7. A functional connection between IIP-1 and the IGF-1 receptor is further supported by the finding that the level of expression of IIP-1 and the IGF-1 receptor strongly correlates in different normal and cancer cells. Furthermore, overexpression of IIP-1 resulted in an attenuation of migration of MCF-7 cells, which is one of the biological activities mediated by the IGF-1 signaling system.
引用
收藏
页码:33419 / 33427
页数:9
相关论文
共 60 条
[1]   APS, an adapter protein with a PH and SH2 domain, is a substrate for the insulin receptor kinase [J].
Ahmed, Z ;
Smith, BJ ;
Kotani, K ;
Wilden, P ;
Pillay, TS .
BIOCHEMICAL JOURNAL, 1999, 341 :665-668
[2]  
[Anonymous], 1997, BIOCH BIOPHYSICA ACT
[3]  
Bartel P, 1993, CELLULAR INTERACTION, P153
[4]   ERBIN:: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor [J].
Borg, JP ;
Marchetto, S ;
Le Bivic, A ;
Ollendorff, V ;
Jaulin-Bastard, F ;
Saito, H ;
Fournier, E ;
Adélaïde, J ;
Margolis, B ;
Birnbaum, D .
NATURE CELL BIOLOGY, 2000, 2 (07) :407-414
[5]   INSULIN-LIKE GROWTH-FACTOR-I AND PLATELET-DERIVED GROWTH FACTOR-BB INDUCE DIRECTED MIGRATION OF HUMAN ARTERIAL SMOOTH-MUSCLE CELLS VIA SIGNALING PATHWAYS THAT ARE DISTINCT FROM THOSE OF PROLIFERATION [J].
BORNFELDT, KE ;
RAINES, EW ;
NAKANO, T ;
GRAVES, LM ;
KREBS, EG ;
ROSS, R .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :1266-1274
[6]   Inhibition of the type 1 insulin-like growth factor receptor expression and signaling: Novel strategies for antimetastatic therapy [J].
Brodt, P ;
Samani, A ;
Navab, R .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1101-1107
[7]   The junction-associated protein AF-6 interacts and clusters with specific EPH receptor tyrosine kinases at specialized sites of cell-cell contact in the brain [J].
Buchert, M ;
Schneider, S ;
Meskenaite, V ;
Adams, MT ;
Canaani, E ;
Baechi, T ;
Moelling, K ;
Hovens, CM .
JOURNAL OF CELL BIOLOGY, 1999, 144 (02) :361-371
[8]   Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology [J].
Butler, AA ;
Yakar, S ;
Gewolb, IH ;
Karas, M ;
Okubo, Y ;
LeRoith, D .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1998, 121 (01) :19-26
[9]  
Cai HB, 1999, J NEUROSCI, V19, P6519
[10]   Phosphorylation at Tyr-838 in the kinase domain of EphA8 modulates Fyn binding to the Tyr-615 site by enhancing tyrosine kinase activity [J].
Choi, S ;
Park, S .
ONCOGENE, 1999, 18 (39) :5413-5422